Jeffrey K. Holden

TCI Peptide Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration”.

Allosteric inhibition of HTRA1 activity by a conformational lock mechanism to treat age-related macular degeneration

Nature Communications(2022)10.1038/s41467-022-32760-9

N/A

0DataRank · unranked

19 citations

Mark Ultsch, Wanjian Tang, Evan Green, Jeffrey K. Holden, Wěi Li +6 more

Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7

Structure(2025)10.1016/j.str.2025.01.021

N/A

0DataRank · unranked

3 citations

Francesca Anson, Shannon T. Smith, Mark Ultsch, Connie A. Tenorio, Lionel Rougé +6 more